5 Curious Medical Cases From 2014

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The sNDA for the brexpiprazole plus sertraline therapy is based on positive phase 2 and 3 clinical trials showing improvement in PTSD-specific scale scores.

October 25th 2023

Can Colonoscopy Interval be Safely Extended from 10 to 15 Years for Individuals at Average CRC Risk?

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

New research suggests the interval "could potentially be extended" without significant harms and could reduce unnecessary invasive procedures. , ie, missed early detection and CRC-specific mortality.

August 30th 2023

Nirsevimab for RSV Reduces Infant Hospitalizations by 82% in Real-World Study

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Anxiety Linked to Increased Risk for Acute Exacerbations in Older Adults with COPD

In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).

sNDA for Brexpiprazole/Sertraline Combination for PTSD Submitted for FDA Review

Nearly 20% of an older cohort with COPD reported anxiety that was subsequently associated with more severe symptoms and acute exacerbations.

Related Content

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The sNDA for the brexpiprazole plus sertraline therapy is based on positive phase 2 and 3 clinical trials showing improvement in PTSD-specific scale scores.

October 25th 2023

Can Colonoscopy Interval be Safely Extended from 10 to 15 Years for Individuals at Average CRC Risk?

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

New research suggests the interval "could potentially be extended" without significant harms and could reduce unnecessary invasive procedures. , ie, missed early detection and CRC-specific mortality.

August 30th 2023

Nirsevimab for RSV Reduces Infant Hospitalizations by 82% in Real-World Study

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Anxiety Linked to Increased Risk for Acute Exacerbations in Older Adults with COPD

In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).